Creative review: The Cannes Lions trends that pharma needs t...
Pharma creative needs to stand up and be counted.
Newsletters and Deep Dive digital magazine
Pharma creative needs to stand up and be counted.
Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials.
Europeans are living longer than ever before – tangible proof of the phenomenal advancements in science and healthcare.1,2 However, it comes with a paradoxical rise in nervous sy
In its 60th year, the Drug Information Association (DIA) global annual meeting
One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list.
Editor's Picks
Newsletters and Deep Dive
digital magazine